Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 7/20 | 0.47 |
| ▸ | NPC1 | O15118 | 5/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.47 |
| ▸ | MAPT | P10636 | 6/20 | 0.46 |
| ▸ | MEN1 | O00255 | 6/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.46 |
| ▸ | HTT | P42858 | 4/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | PSIP1 | O75475 | 1/20 | 0.41 |
| ▸ | RORC | P51449 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | CASP7 | P55210 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4063469 | 0.83 | KMT2A (0.37) | RAB9ANPC1SMN1; SMN2MAPTMEN1 | |
| SCHEMBL30335 | 0.74 | NPC1 (0.49) | RAB9ANPC1MAPTMEN1KMT2A | |
| SCHEMBL31374378 | 0.74 | MAPK1 (0.49) | RAB9ANPC1SMN1; SMN2MAPTMEN1 | |
| SCHEMBL7208909 | 0.74 | MAPK1 (0.49) | RAB9ANPC1SMN1; SMN2MAPTMEN1 | |
| SCHEMBL11045869 | 0.74 | MEN1 (0.43) | RAB9ANPC1MAPTMEN1KMT2A | |
| SCHEMBL950729 | 0.74 | MAPK1 (0.60) | RAB9ANPC1SMN1; SMN2MAPTMEN1 | |
| SCHEMBL45337 | 0.74 | MAPT (0.47) | RAB9ANPC1SMN1; SMN2MAPTMEN1 | |
| SCHEMBL2333439 | 0.74 | HSD17B10 (0.48) | RAB9ANPC1SMN1; SMN2MAPTKMT2A | |
| Nitric Acid SCHEMBL20984275 | 0.74 | RAB9A (0.47) | RAB9ANPC1SMN1; SMN2MAPTMEN1 | |
| SCHEMBL11570570 | 0.74 | ALDH1A1 (0.34) | RAB9ANPC1SMN1; SMN2MAPTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4719391-A2 | TRIPLE KINASE INHIBITORS | Unogen Biotech Ltd. (US) | 2026-04-08 | — | — | EP | disclosed |
| US-20260085050-A1 | TRIPLE KINASE INHIBITORS | UNOGEN BIOTECH LTD (US) | 2026-03-26 | — | — | US | disclosed |
| WO-2024249831-A2 | TRIPLE KINASE INHIBITORS | UNOGEN BIOTECH LTD. (US) | 2024-12-05 | — | — | WO | disclosed |
| EP-3215499-B1 | IMINOSUGARS USEFUL FOR THE TREATMENT OF VIRAL DISEASES | EMERGENT VIROLOGY LLC (US) | 2021-01-20 | — | — | EP | disclosed |
| CN-111655677-A | Benzimidazole compounds as agrochemicals | 瑞戴格作物保护公司 | 2020-09-11 | — | — | CN | disclosed |
| CN-111542517-A | Benzimidazole compounds as agrochemicals | 瑞戴格作物保护公司 | 2020-08-14 | — | — | CN | disclosed |
| US-10428022-B2 | Iminosugars useful for the treatment of viral diseases | EMERGENT VIROLOGY LLC (US) | 2019-10-01 | — | — | US | disclosed |
| US-20180273473-A1 | IMINOSUGARS USEFUL FOR THE TREATMENT OF VIRAL DISEASES | EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. | 2018-09-27 | — | — | US | disclosed |
| EP-3215499-A1 | IMINOSUGARS USEFUL FOR THE TREATMENT OF VIRAL DISEASES | Emergent Virology LLC (US) | 2017-09-13 | — | — | EP | disclosed |
| WO-2016073652-A1 | IMINOSUGARS USEFUL FOR THE TREATMENT OF VIRAL DISEASES | UNITHER VIROLOGY, LLC (US) | 2016-05-12 | — | — | WO | disclosed |
| US-6780998-B2 | DEVELOPER-COUPLER SUBSTANCE COMBINATION HAIR DYES | WELLA AKTIENGESELLSCHAFT (DE) | 2004-08-24 | — | — | US | disclosed |
| US-20020189033-A1 | Substituted 2-aminoalkyl-1,4diaminobenzene compounds and oxidation dye precursor compositions containing same | WELLA INTERNATIONAL OPERATIONS SWITZERLAND SARL (CH) | 2002-12-19 | — | — | US | disclosed |
| US-5685881-A | Aromatic allylaminonitro compounds, hair dye compositions containing aromatic allylaminonitio compounds, and synthetic and natural fiber dyeing process | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1997-11-11 | — | — | US | disclosed |
| EP-0671900-B1 | ALLYLAMINO-NITROAROMATES | HENKEL KGAA (DE) | 1996-08-14 | — | — | EP | disclosed |
| EP-0671900-A1 | ALLYLAMINO-NITROAROMATES. | HENKEL KGAA (DE) | 1995-09-20 | — | — | EP | disclosed |
| WO-1994012149-A1 | ALLYLAMINO-NITROAROMATES | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1994-06-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260085050-A1 | TRIPLE KINASE INHIBITORS | ALK, ERBB2, ERBB3 | RAB9A 1264/4885NPC1 1543/4885SMN1; SMN2 3559/4885 |
| US-10428022-B2 | Iminosugars useful for the treatment of viral diseases | GBA1, MAN2B1, GBA2 | RAB9A 1251/4885NPC1 36/4885SMN1; SMN2 706/4885 |
| US-20020189033-A1 | Substituted 2-aminoalkyl-1,4diaminobenzene compounds and oxidation dye precursor compositions containing same | DDT, CYP1B1, ALDH7A1 | RAB9A 4496/4885NPC1 4319/4885SMN1; SMN2 4489/4885 |
| US-20180273473-A1 | IMINOSUGARS USEFUL FOR THE TREATMENT OF VIRAL DISEASES | GBA1, MAN2B1, GBA2 | RAB9A 1251/4885NPC1 36/4885SMN1; SMN2 706/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.